As the research on cancer-related treatment deepens, integrating traditional therapies with
emerging interventions reveals new therapeutic possibilities. Melittin and phospholipase A2 …

Microbial contamination poses a serious threat to human life and health. Through the
intersection of material science and modern medicine, advanced bionic hydrogels have …

Melittin (MLT) has been studied preclinically as an anticancer agent based on its broad lytic
effects in multiple tumor types. However, unsatisfactory tissue distribution, hemolysis, rapid …

With the rapid development of molecular biology and biochemical technology, great
progress has been made in the study of peptides. Peptides are easy to digest and absorb …

Compared with small-molecule synthetic drugs, bioactive peptides have desirable
advantages in efficiency, selectivity, safety, tolerance, and side effects, which are accepted …

Hydrogel exhibits a promising application prospect for multimodal cancer therapy in clinic
compared with other conventional drug delivery platforms, which is predominantly attributed …

Background Development of promising medicines from natural sources, specially venom, is
of highly necessitated to combat against life-threatening cancers. Non-small cell lung cancer …

The development of peptide-based materials is one of the most challenging aspects of
biomaterials research in recent years. The assembly of peptides is mainly controlled by …

Biomacromolecule drugs of nucleic acids and proteins/peptides have occupied growing
share of global pharmaceutical market, but their biomedical application faces substantial …

Oncolytic peptides (OLPs) with membranolytic activity show great potential to combat
multidrug-resistant cancer cells. Herein, we report a cationic helical oncolytic polypeptide …